Neuronetics (STIM) Cash from Financing Activities (2017 - 2026)

Neuronetics (STIM) reported Cash from Financing Activities of -$5.6 million for Q1 2026, down 129.39% year-over-year from $19.0 million in Q1 2025, and down 441.98% quarter-over-quarter from -$1.0 million in Q4 2025.

Neuronetics (STIM) Cash from Financing Activities (2017 - 2026) Analysis & Trends

Neuronetics (STIM) has 10 years of Cash from Financing Activities data on file, last reported at -$5.6 million in Q1 2026.

  • Cash from Financing Activities for Q1 2026 came in at -$5.6 million, down 129.39% year-over-year; the trailing twelve-month figure through Mar 2026 was $11.3 million (down 77.76% YoY), and the FY2025 annual result was $35.8 million, up 626.59% from the prior year.
  • Cash from Financing Activities slipped to -$5.6 million in Q1 2026 per STIM's latest filing, from -$1.0 million in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $22.3 million in Q4 2023 and troughed at -$5.6 million in Q1 2026.
  • A 5-year average of $5.2 million and a median of $127500.0 in 2022 frame the typical range for Cash from Financing Activities.
  • On a YoY basis, Cash from Financing Activities climbed as much as 8985.71% in 2023 and fell as far as 720.0% in 2023.
  • A 5-year view of Cash from Financing Activities shows it stood at $245000.0 in 2022, then soared by 8985.71% to $22.3 million in 2023, then plunged by 57.04% to $9.6 million in 2024, then slumped by 110.76% to -$1.0 million in 2025, then slumped by 441.98% to -$5.6 million in 2026.
  • Business Quant data shows STIM's Cash from Financing Activities at -$5.6 million in Q1 2026, -$1.0 million in Q4 2025, and $17.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 17.31 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn -1.51 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn -2.09 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn -260.00 Mn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -451.20 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -26.93 Mn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -25.00 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 21.00 Mn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -97.90 Mn
10 Neuronetics 2.40 Mn -7.28 Mn 16.15 Mn -5.58 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -5.58 Mn
Mar 31, 2026 -5.58 Mn
Dec 31, 2025 -1.03 Mn
Dec 31, 2025 -1.03 Mn
Sep 30, 2025 17.90 Mn
Sep 30, 2025 17.90 Mn
Jun 30, 2025 1,000.00
Jun 30, 2025 1,000.00
Mar 31, 2025 18.98 Mn
Mar 31, 2025 18.98 Mn
Dec 31, 2024 9.56 Mn
Dec 31, 2024 9.56 Mn
Dec 31, 2023 22.26 Mn
Dec 31, 2023 22.26 Mn
Jun 30, 2023 -62,000.00
Jun 30, 2023 -62,000.00
Mar 31, 2023 499,000.00
Mar 31, 2023 499,000.00
Dec 31, 2022 245,000.00
Dec 31, 2022 245,000.00